The estimated Net Worth of William Wei Zuo is at least $1.93 Миллион dollars as of 4 March 2021. William Zuo owns over 419,931 units of Athenex Inc stock worth over $28,577 and over the last 7 years he sold ATNX stock worth over $1,898,088. In addition, he makes $0 as President и China Division at Athenex Inc.
William has made over 2 trades of the Athenex Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 419,931 units of ATNX stock worth $1,898,088 on 4 March 2021.
The largest trade he's ever made was selling 419,931 units of Athenex Inc stock on 4 March 2021 worth over $1,898,088. On average, William trades about 46,770 units every 79 days since 2017. As of 4 March 2021 he still owns at least 142,883 units of Athenex Inc stock.
You can see the complete history of William Zuo stock trades at the bottom of the page.
Dr. William W. Zuo Ph.D. serves as President, China Division of the Company. Dr. Zuo joined our company in 2015 as President of our China operations in conjunction with our acquisition of Polymed Therapeutics. Dr. Zuo had served as President of Polymed Therapeutics since 1995 and Chairman of Chongqing Taihao Pharmaceutical since 2012. Dr. Zuo’s career has focused on the development, manufacture, and sale and marketing of various complex API on a global basis, especially injectable oncology active pharmaceutical ingredients. Dr. Zuo was the chief executive officer of the Fibrocell Science Group Companies in Asia from 2010 to 2013. Dr. Zuo oversaw the introduction of the U.S. FDA approved cell therapeutics product, LaViv, to the Asia market. He has overseen the construction of multiple current Good Manufacturing Practices (“cGMP”) facilities in China and has extensive experience with the Food and Drug Administrations in both China and the United States. Dr. Zuo received his Ph.D in Nanotechnology from Rice University where he worked extensively with Dr. Richard Smalley, the late Nobel Prize Scholar in Chemistry. Dr. Zuo also has Master degrees in Chemical Engineering and Applied Mathematics from Rice University.
William Zuo is 58, he's been the President и China Division of Athenex Inc since 2015. There are 12 older and 5 younger executives at Athenex Inc. The oldest executive at Athenex Inc is John Vierling, 74, who is the Independent Director.
William's mailing address filed with the SEC is C/O ATHENEX, INC., 1001 MAIN STREET, SUITE 600, BUFFALO, NY, 14203.
Over the last 7 years, insiders at Athenex Inc have traded over $33,215,399 worth of Athenex Inc stock and bought 5,920,005 units worth $73,651,360 . The most active insiders traders include Advisors Llcperceptive Life..., Song Yi Zhang и Song Yi Mandra Medical Ltd .... On average, Athenex Inc executives and independent directors trade stock every 12 days with the average trade being worth of $10,843. The most recent stock trade was executed by Joe Annoni on 22 February 2023, trading 625 units of ATNX stock currently worth $125.
athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. the company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. our business includes medical technology innovation centers and a unique manufacturing supply chain across both china and north america. through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
Athenex Inc executives and other stock owners filed with the SEC include: